Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Methyl-Donor Rich Diet in the Postpartum Period

Official title: The Effect of a Methyl Donor-Rich Diet in the Postpartum Period on Maternal Depression Levels, Breastfeeding Success and Infant Weight: A Randomized Controlled Trial

Run by Istanbul University - Cerrahpasa · NCT07887178 · Data updated 2026-11-12

Researchers will test whether a methyl-donor‑rich diet in the first weeks after birth helps reduce maternal depression and supports breastfeeding and infant growth.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment100 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Bursa, Orhaneli̇)
StatusRecruiting
StartedMay 21, 2026
Main results expectedOctober 2027
Study endsDecember 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07887178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Postpartum women aged 18–40 who have delivered term infants and are exclusively breastfeeding, with low intake of at least one methyl-donor nutrient on a 3-day record.

Probably not a fit

Women with no low methyl-donor nutrients or who have contraindications to dietary changes may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 100 postpartum women in Bursa, Türkiye, who have low intake of key methyl-donor nutrients. Participants will be randomly assigned to receive a two-month, individualized methyl-donor–rich diet and nutrition education or standard postpartum care. The study will compare maternal depressive symptoms, breastfeeding success, and infant weight between groups, with dietary intake monitored throughout. Eligibility emphasizes recent delivery, exclusive breastfeeding, and adequate health without psychiatric conditions or major comorbidities. The trial aims to determine if targeted nutrition can influence mood, feeding outcomes, and early infant growth.

Why it matters

Potential benefit: If successful, the diet approach could improve maternal mood, support breastfeeding, and promote healthy infant weight gain.

How similar studies have gone: Prior studies on methyl-donor nutrition in the postpartum period are limited; this trial explores a novel, targeted dietary approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18-40 years.
* Women presenting within the first 15 days after delivery.
* Mothers who had a term delivery (≥37 completed weeks of gestation).
* Mothers who are breastfeeding and whose infants are exclusively breastfed.
* No diagnosed psychiatric disorder or related medication use.
* No use of dietary supplements, including omega-3 supplements.
* No special diet program.
* No history of gestational diabetes, type 1 or type 2 diabetes, or insulin resistance.
* No malabsorption-related disorders, such as celiac disease or Crohn's disease.
* At least one assessed methyl donor nutrient intake below two-thirds of the applicable recommended intake, based on a 3-day dietary record.
* Willingness to participate voluntarily.

Exclusion Criteria:

* Development of serious postpartum complications, such as postpartum hemorrhage or sepsis.
* A maternal or infant health condition requiring prolonged hospitalization.
* Introduction of complementary foods to the infant during the study.
* Maternal smoking or alcohol use.
* Failure to adhere to the dietary intervention.
* Failure to attend follow-up assessments or voluntary withdrawal from the study.

Where it's running

  • Orhaneli Merkez Aile Sağlığı Merkezi
    Bursa, Orhaneli̇, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.